Itraconazole Oral Suspension
FDA identified interpretive criteria:
|
Minimum Inhibitory |
Disk Diffusion
|
||||
---|---|---|---|---|---|---|
Pathogen |
S |
I |
R |
S |
I |
R |
Candida albicansa |
≤ 0.125 |
0.25 – 0.5 |
> 1 |
- |
- |
- |
S = Susceptible; I = Intermediate; R = Resistant
a Mucosal isolates only